PHILLIP BANKSTON: Open Payments
NPI 1518453695 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $750 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 5 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $113 |
| ABBVIE INC. | 4 | $105 |
| Corium, LLC | 4 | $84 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Alkermes, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: Dyanavel XR, CAPLYTA, VRAYLAR, Azstarys, INGREZZA, Jornay PM, ARISTADA, TRINTELLIX.
Industry payments across CO — which companies pay providers there.
